Scientific Programme - 2nd EAU Update on Prostate Cancer Meeting

View programme as: Grid view List view
Print: Print
Personal Planner

06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00

Plenary room
Red 1
Red 2
Blue 1
Blue 2
Catering & Exhibition

1. 06:00
2. 07:00
3. 08:00
4. 09:00
5. 10:00
6. 11:00
7. 12:00
8. 13:00
9. 14:00
10. 15:00
11. 16:00
12. 17:00
13. 18:00
14. 19:00
15. 20:00
16. 21:00
Plenary room
1. Plenary Session - Introduction and format of the meeting
  
  Introduction and format of the meeting Plenary Session
  
  08:00 - 08:05
  Introduction and format of the meeting
  
  Plenary Session
  
  Fri 14 September
  08:00 - 08:05
  
  Location:
  
  Plenary room
  
  Chairs:
  
  J. Palou, Barcelona (ES)
  M. Wirth, Dresden (DE)
2. Systemic treatment - Systemic treatment
  
  Systemic treatment Systemic treatment
  
  08:00 - 09:00
  Systemic treatment
  
  Systemic treatment
  
  Sat 15 September
  08:00 - 09:00
  
  Location:
  
  Plenary room
  
  Chairs:
  
  J. Palou, Barcelona (ES)
  M. Wirth, Dresden (DE)
  
  08:00 - 08:20
  
  Update on trial results in mHSPC
  
  R.J.A. Van Moorselaar, Amsterdam (NL)
  
  08:20 - 08:40
  
  mCRPC: Which drugs and in what sequence?
  
  P. Cornford, Liverpool (GB)
  
  08:40 - 09:00
  
  When and how to use bone-protective agents
  
  V.A.C. Ramani, Manchester (GB)
3. Plenary Session - Update on diagnosis and staging
  
  Update on diagnosis and staging Plenary Session
  
  08:05 - 08:50
  Update on diagnosis and staging
  
  Plenary Session
  
  Fri 14 September
  08:05 - 08:50
  
  Location:
  
  Plenary room
  
  Chairs:
  
  A.S. Merseburger, Lübeck (DE)
  N. Mottet, Saint-Étienne (FR)
  
  08:05 - 08:20
  
  When to use MRI in the diagnosis of prostate cancer?
  
  G. Villeirs, Ghent (BE)
  
  08:20 - 08:35
  
  Prostate biopsy: fusion, systematic or both?
  
  W.L.M. Everaerts, Leuven (BE)
  
  08:35 - 08:50
  
  Is there a place for PET scanning in the primary diagnosis of prostate cancer?
  
  W. Oyen, London (GB)
4. Round table discussions - Round table discussions
  
  Round table discussions Round table discussions
  
  14:15 - 15:15
  Round table discussions
  
  Round table discussions
  
  Sat 15 September
  14:15 - 15:15
  
  Location:
  
  Plenary room
  
  14:15 - 14:45
  
  Focal therapy in 2018: Still experimental?
  
  M. Emberton, London (GB)
  
  14:45 - 15:15
  
  Novel treatments options in mCRPC such as immunotherapy and radioligands
  
  A. Bergman, Amsterdam (NL)
5. Update on local treatment - Update on local treatment
  
  Update on local treatment Update on local treatment
  
  14:20 - 14:55
  Update on local treatment
  
  Update on local treatment
  
  Fri 14 September
  14:20 - 14:55
  
  Location:
  
  Plenary room
  
  Chairs:
  
  S. Joniau, Leuven (BE)
  R.J.A. Van Moorselaar, Amsterdam (NL)
  
  14:20 - 14:40
  
  Who is the optimal candidate for local treatment?
  A. Bossi, Villejuif (FR)
  N. Mottet, Saint-Étienne (FR)
  
  14:40 - 14:55
  
  Salvage treatment for recurrent disease
  
  A. Briganti, Milan (IT)
6. Take home messages and final remarks - Take home messages and final remarks
  
  Take home messages and final remarks Take home messages and final remarks
  
  15:15 - 15:30
  Take home messages and final remarks
  
  Take home messages and final remarks
  
  Sat 15 September
  15:15 - 15:30
  
  Location:
  
  Plenary room
  
  -
  
  A. Briganti, Milan (IT)
  
  -
  
  S. Joniau, Leuven (BE)
  
  -
  
  A.S. Merseburger, Lübeck (DE)
  
  -
  
  N. Mottet, Saint-Étienne (FR)
  
  -
  
  R.J.A. Van Moorselaar, Amsterdam (NL)
Red 1
1. Plenary session - Case discussions: 1
  
  Case discussions: 1 Plenary session
  
  08:50 - 13:20
  Case discussions: 1
  
  Plenary session
  
  Fri 14 September
  08:50 - 13:20
  
  Location:
  
  Red 1
  
  08:50 - 09:50
  
  Patient selection for prostate biopsy
  M. Emberton, London (GB)
  S. Joniau, Leuven (BE)
  
  09:50 - 10:50
  
  How to use PSA in 2018
  J. Stranne, Göteborg (SE)
  N. Mottet, Saint-Étienne (FR)
  
  10:50 - 11:20
  
  Coffee break
  
  11:20 - 12:20
  
  Which imaging after initial prostate cancer diagnosis
  W. Oyen, London (GB)
  G. Villeirs, Ghent (BE)
  
  12:20 - 13:20
  
  Genomics in prostate cancer, when and how to use it
  J. Walz, Marseille (FR)
  W.R. Gerritsen, Nijmegen (NL)
2. Plenary session - Case discussions: 3
  
  Case discussions: 3 Plenary session
  
  09:00 - 12:30
  Case discussions: 3
  
  Plenary session
  
  Sat 15 September
  09:00 - 12:30
  
  Location:
  
  Red 1
  
  09:00 - 10:00
  
  Treatment of oligometastatic disease
  P. Ost, Ghent (BE)
  A. Briganti, Milan (IT)
  
  10:00 - 11:00
  
  Treatment of mHSPC
  A.S. Merseburger, Lübeck (DE)
  P. Cornford, Liverpool (GB)
  
  11:00 - 11:30
  
  Coffee break
  
  11:30 - 12:30
  
  Treatment of CRPC
  C. Thomas, Mainz (DE)
  M. Lolkema, ()
  
  12:30 - 13:30
  
  Local treatment in M+ PCa
  P. Sooriakumaran, London (GB)
  N. Fossati, Milan (IT)
3. Plenary session - Case discussions: 2
  
  Case discussions: 2 Plenary session
  
  14:55 - 19:25
  Case discussions: 2
  
  Plenary session
  
  Fri 14 September
  14:55 - 19:25
  
  Location:
  
  Red 1
  
  14:55 - 15:55
  
  Technical aspects of open and robotic radical prostatectomy
  M. Graefen, Hamburg (DE)
  H.G. Van Der Poel, Amsterdam (NL)
  
  15:55 - 16:55
  
  Active surveillance: patient selection and follow-up
  M. Roobol, Rotterdam (NL)
  O. Bratt, Gothenburg (SE)
  
  16:55 - 17:25
  
  Coffee break
  
  17:25 - 18:25
  
  What urologists need to know about radiotherapy
  M. Mason, Cardiff (GB)
  A. Bossi, Villejuif (FR)
  
  18:25 - 19:25
  
  Salvage local treatment
  A. Heidenreich, Cologne (DE)
  G. De Meerleer, Ghent (BE)
Red 2
1. Plenary session - Case discussions: 1
  
  Case discussions: 1 Plenary session
  
  08:50 - 13:20
  Case discussions: 1
  
  Plenary session
  
  Fri 14 September
  08:50 - 13:20
  
  Location:
  
  Red 2
  
  08:50 - 09:50
  
  How to use PSA in 2018
  J. Stranne, Göteborg (SE)
  N. Mottet, Saint-Étienne (FR)
  
  09:50 - 10:50
  
  Which imaging after initial prostate cancer diagnosis
  W. Oyen, London (GB)
  G. Villeirs, Ghent (BE)
  
  10:50 - 11:20
  
  Coffee break
  
  11:20 - 12:20
  
  Genomics in prostate cancer, when and how to use it
  J. Walz, Marseille (FR)
  W.R. Gerritsen, Nijmegen (NL)
  
  12:20 - 13:20
  
  Patient selection for prostate biopsy
  M. Emberton, London (GB)
  S. Joniau, Leuven (BE)
2. Plenary session - Case discussions: 3
  
  Case discussions: 3 Plenary session
  
  09:00 - 12:30
  Case discussions: 3
  
  Plenary session
  
  Sat 15 September
  09:00 - 12:30
  
  Location:
  
  Red 2
  
  09:00 - 10:00
  
  Treatment of mHSPC
  A.S. Merseburger, Lübeck (DE)
  P. Cornford, Liverpool (GB)
  
  10:00 - 11:00
  
  Treatment of CRPC
  C. Thomas, Mainz (DE)
  M. Lolkema, Rotterdam (NL)
  
  11:00 - 11:30
  
  Coffee break
  
  11:30 - 12:30
  
  Local treatment in M+ PCa
  P. Sooriakumaran, London (GB)
  N. Fossati, Milan (IT)
  
  12:30 - 13:30
  
  Treatment of oligometastatic disease
  P. Ost, Ghent (BE)
  A. Briganti, Milan (IT)
3. Plenary session - Case discussions: 2
  
  Case discussions: 2 Plenary session
  
  14:55 - 19:25
  Case discussions: 2
  
  Plenary session
  
  Fri 14 September
  14:55 - 19:25
  
  Location:
  
  Red 2
  
  14:55 - 15:55
  
  Active surveillance: patient selection and follow-up
  M. Roobol, Rotterdam (NL)
  O. Bratt, Gothenburg (SE)
  
  15:55 - 16:55
  
  What urologists need to know about radiotherapy
  M. Mason, Cardiff (GB)
  A. Bossi, Villejuif (FR)
  
  16:55 - 17:25
  
  Coffee break
  
  17:25 - 18:25
  
  Salvage local treatment
  A. Heidenreich, Cologne (DE)
  G. De Meerleer, Ghent (BE)
  
  18:25 - 19:25
  
  Technical aspects of open and robotic radical prostatectomy
  M. Graefen, Hamburg (DE)
  H.G. Van Der Poel, Amsterdam (NL)
Blue 1
1. Plenary session - Case discussions: 1
  
  Case discussions: 1 Plenary session
  
  08:50 - 13:20
  Case discussions: 1
  
  Plenary session
  
  Fri 14 September
  08:50 - 13:20
  
  Location:
  
  Blue 1
  
  08:50 - 09:50
  
  Which imaging after initial prostate cancer diagnosis
  W. Oyen, London (GB)
  G. Villeirs, Ghent (BE)
  
  09:50 - 10:50
  
  Genomics in prostate cancer, when and how to use it
  J. Walz, Marseille (FR)
  W.R. Gerritsen, Nijmegen (NL)
  
  10:50 - 11:20
  
  Coffee break
  
  11:20 - 12:20
  
  Patient selection for prostate biopsy
  M. Emberton, London (GB)
  S. Joniau, Leuven (BE)
  
  12:20 - 13:20
  
  How to use PSA in 2018
  J. Stranne, Göteborg (SE)
  N. Mottet, Saint-Étienne (FR)
2. Plenary session - Case discussions: 3
  
  Case discussions: 3 Plenary session
  
  09:00 - 12:30
  Case discussions: 3
  
  Plenary session
  
  Sat 15 September
  09:00 - 12:30
  
  Location:
  
  Blue 1
  
  09:00 - 10:00
  
  Treatment of CRPC
  C. Thomas, Mainz (DE)
  M. Lolkema, ()
  
  10:00 - 11:00
  
  Local treatment in M+ PCa
  P. Sooriakumaran, London (GB)
  N. Fossati, Milan (IT)
  
  11:00 - 11:30
  
  Coffee break
  
  11:30 - 12:30
  
  Treatment of oligometastatic disease
  P. Ost, Ghent (BE)
  A. Briganti, Milan (IT)
  
  12:30 - 13:30
  
  Treatment of mHSPC
  A.S. Merseburger, Lübeck (DE)
  P. Cornford, Liverpool (GB)
3. Plenary session - Case discussions: 2
  
  Case discussions: 2 Plenary session
  
  14:55 - 19:25
  Case discussions: 2
  
  Plenary session
  
  Fri 14 September
  14:55 - 19:25
  
  Location:
  
  Blue 1
  
  14:55 - 15:55
  
  What urologists need to know about radiotherapy
  M. Mason, Cardiff (GB)
  A. Bossi, Villejuif (FR)
  
  15:55 - 16:55
  
  Salvage local treatment
  A. Heidenreich, Cologne (DE)
  G. De Meerleer, Ghent (BE)
  
  16:55 - 17:25
  
  Coffee break
  
  17:25 - 18:25
  
  Technical aspects of open and robotic radical prostatectomy
  M. Graefen, Hamburg (DE)
  H.G. Van Der Poel, Amsterdam (NL)
  
  18:25 - 19:25
  
  Active surveillance: patient selection and follow-up
  M. Roobol, Rotterdam (NL)
  O. Bratt, Gothenburg (SE)
Blue 2
1. Plenary session - Case discussions: 1
  
  Case discussions: 1 Plenary session
  
  08:50 - 13:20
  Case discussions: 1
  
  Plenary session
  
  Fri 14 September
  08:50 - 13:20
  
  Location:
  
  Blue 2
  
  08:50 - 09:50
  
  Genomics in prostate cancer, when and how to use it
  J. Walz, Marseille (FR)
  W.R. Gerritsen, Nijmegen (NL)
  
  09:50 - 10:50
  
  Patient selection for prostate biopsy
  M. Emberton, London (GB)
  S. Joniau, Leuven (BE)
  
  10:50 - 11:20
  
  Coffee break
  
  11:20 - 12:20
  
  How to use PSA in 2018
  J. Stranne, Göteborg (SE)
  N. Mottet, Saint-Étienne (FR)
  
  12:20 - 13:20
  
  Which imaging after initial prostate cancer diagnosis
  W. Oyen, London (GB)
  G. Villeirs, Ghent (BE)
2. Plenary session - Case discussions: 3
  
  Case discussions: 3 Plenary session
  
  09:00 - 12:30
  Case discussions: 3
  
  Plenary session
  
  Sat 15 September
  09:00 - 12:30
  
  Location:
  
  Blue 2
  
  09:00 - 10:00
  
  Local treatment in M+ PCa
  P. Sooriakumaran, London (GB)
  N. Fossati, Milan (IT)
  
  10:00 - 11:00
  
  Treatment of oligometastatic disease
  P. Ost, Ghent (BE)
  A. Briganti, Milan (IT)
  
  11:00 - 11:30
  
  Coffee break
  
  11:30 - 12:30
  
  Treatment of mHSPC
  A.S. Merseburger, Lübeck (DE)
  P. Cornford, Liverpool (GB)
  
  12:30 - 13:30
  
  Treatment of CRPC
  C. Thomas, Mainz (DE)
  M. Lolkema, ()
3. Plenary session - Case discussions: 2
  
  Case discussions: 2 Plenary session
  
  14:55 - 19:25
  Case discussions: 2
  
  Plenary session
  
  Fri 14 September
  14:55 - 19:25
  
  Location:
  
  Blue 2
  
  14:55 - 15:55
  
  Salvage local treatment
  A. Heidenreich, Cologne (DE)
  G. De Meerleer, Ghent (BE)
  
  15:55 - 16:55
  
  Technical aspects of open and robotic radical prostatectomy
  M. Graefen, Hamburg (DE)
  H.G. Van Der Poel, Amsterdam (NL)
  
  16:55 - 17:25
  
  Coffee break
  
  17:25 - 18:25
  
  Active surveillance: patient selection and follow-up
  M. Roobol, Rotterdam (NL)
  O. Bratt, Gothenburg (SE)
  
  18:25 - 19:25
  
  What urologists need to know about radiotherapy
  M. Mason, Cardiff (GB)
  A. Bossi, Villejuif (FR)
Catering & Exhibition
1. Coffee Break Friday
  
  Coffee Break Friday
  
  10:50 - 11:20
2. Break
  
  Break
  
  11:00 - 11:30
3. Lunch Break Friday - Lunch break
  
  Lunch break Lunch Break Friday
  
  13:20 - 14:20
  Lunch break
  
  Lunch Break Friday
  
  Fri 14 September
  13:20 - 14:20
  
  Location:
  
  Catering & Exhibition
4. Saturday Coffee Break
  
  Saturday Coffee Break
  
  13:30 - 14:15
5. Coffee Break Friday
  
  Coffee Break Friday
  
  16:55 - 17:25

PCa18

Plenary room

Red 1

Red 2

Blue 1

Blue 2

Catering & Exhibition

Plenary room

Introduction and format of the meeting

Systemic treatment

Update on diagnosis and staging

Round table discussions

Update on local treatment

Take home messages and final remarks

Red 1

Case discussions: 1

Case discussions: 3

Case discussions: 2

Red 2

Case discussions: 1

Case discussions: 3

Case discussions: 2

Blue 1

Case discussions: 1

Case discussions: 3

Case discussions: 2

Blue 2

Case discussions: 1

Case discussions: 3

Case discussions: 2

Catering & Exhibition

Lunch break

Print Your Selection